MétaCan
Menu
Back to cohort
Record W2793152649 · doi:10.1093/ecco-jcc/jjx180.522

P395 Dermatological reactions associated with anti–TNF therapy in inflammatory bowel disease- an 12 year experience

2018· article· en· W2793152649 on OpenAlexaboutno aff
Anirudh Bhandare, Rizwan Diyar, Jo Taylor, Jimmy K. Limdi

Bibliographic record

VenueJournal of Crohn s and Colitis · 2018
Typearticle
Languageen
FieldMedicine
TopicAutoimmune Bullous Skin Diseases
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineInfliximabAdalimumabInflammatory bowel diseaseDermatologyRashEtanerceptItchingAcneIncidence (geometry)Internal medicineUlcerative colitisPsoriasisDiseaseRetrospective cohort studySurgeryTumor necrosis factor alpha

Abstract

fetched live from OpenAlex

Anti-TNF therapies have significantly influenced our treatment paradigms and are amongst our most effective therapies to induce and maintain remission. They are, however, not without side effects. Data on dermatological complications are limited. Our aim was to describe the incidence, management and outcome of dermatological complications of anti-TNF therapy in IBD patients at our centre. We conducted a retrospective review of 435 consecutive IBD patients treated with anti-TNF (Infliximab or Adalimumab) therapy between 2005 and 2017. Data were collected from electronic case records and included demographics, disease characteristics, medical history, treatment and dermatological complications. Forty-four patients (10.1%) had dermatological complications. Of these, 25 were female (56.8%). Thirty-four patients had Crohn’s disease (CD = 77.2%) and 10 had ulcerative colitis (UC = 22.8%). Disease phenotype in CD was A2(24) L3(22) B1(21) in respective categories whereas 7/10 UC patients had Montreal E3 disease. Mean age at diagnosis was 34.31 years (median 28, IQR 23.5). Thirty-four patients were treated with Infliximab. The most common reaction reported was a non-specific rash in 11 patients, eczema in 8, and psoriasiform reactions in 7 patients. Shingles was noted in 5 cases and 3 patients had urticaria. Seborrheic dermatitis, cellulitis, itching, acne, and skin abscesses were noted in two patients each along with one case each of Lichen planus and chicken pox. The average time of onset of symptoms from initiation of treatment was 20 months(median 7, IQR 27). Twenty of 34 patients treated with infliximab, continued treatment following the dermatological side effect without any further reactions,12 were switched to adalimumab of which 1 patient had a further psoriasiform reaction leading to cessation of Anti TNF therapy and initiation of ustekinumab. One patient was not given any further Anti-TNF treatment after the initial reaction and one patient was switched to ustekinumab after the reaction. Of 10 patients on adalimumab who had dermatological side effects, all continued on therapy without any further reactions. The incidence of dermatological effects was 10.1% in our cohort. We did not observe a “class effect” as after switching to a different anti TNF the tolerability was good. Dermatological events were more common in patients with colonic CD treated with infliximab. Further studies on cumulative dermatological effects, risk factors, time to event and outcomes are underway at our institution.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.307

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.017
GPT teacher head0.276
Teacher spread0.259 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2018
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Crohn s and ColitisSame topicAutoimmune Bullous Skin DiseasesFrench-language works237,207